Literature DB >> 9697255

Mortality from respiratory tuberculosis in Switzerland.

H L Rieder1, M Zwahlen, H Zimmermann.   

Abstract

Since 1901, the Swiss Federal Office of Statistics has published at least each decade detailed mortality statistics from tuberculosis. These cross-sectional data on deaths from respiratory tuberculosis from 1901 to 1991 were utilized to analyse retrospectively tuberculosis death experience within each birth cohort. The cross-sectional data indicate that tuberculosis mortality increases with age in each successive decade. Nevertheless, the cohort-contour approach indicates that this phenomenon is the result of a much higher mortality that each cohort experienced in their early adulthood, and that mortality form respiratory tuberculosis in Switzerland always preferentially affected the young. The data also indicate that tuberculosis mortality in Switzerland has been decreasing for at least 160 years, and perhaps peaked as early as in the eighteenth century.

Entities:  

Mesh:

Year:  1998        PMID: 9697255     DOI: 10.1007/bf01359724

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  4 in total

1.  Mortality from non-malignant respiratory diseases in Andalusia, Spain, 1975-1997.

Authors:  M Ruiz-Ramos; J L López-Campos; E Rodríguez-Becerra
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland.

Authors:  Kathrin Zürcher; Marcel Zwahlen; Marie Ballif; Hans L Rieder; Matthias Egger; Lukas Fenner
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

3.  Year of birth effects in the historical decline of tuberculosis mortality: a reconsideration.

Authors:  Romola J Davenport
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

4.  Tuberculosis Mortality and Living Conditions in Bern, Switzerland, 1856-1950.

Authors:  Kathrin Zürcher; Marie Ballif; Marcel Zwahlen; Hans L Rieder; Matthias Egger; Lukas Fenner
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.